Holdings of VANGUARD HEALTH CARE INDEX FUND
VANGUARD WORLD FUND · Original filing · Compare with another fund · Report an error
- Net assets
- 20.3B $ including 20.2B $ in equities, 99.7 %
- Positions
- 408 in 9 countries
- Top ten
- 50.3 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 301 | ORIC Pharmaceuticals Inc | 131,478 | 1.8M $ | 0.01 % |
| 302 | MiMedx Group Inc | 357,721 | 1.7M $ | 0.01 % |
| 303 | Embecta Corp | 167,680 | 1.7M $ | 0.01 % |
| 304 | Ocugen Inc | 939,571 | 1.7M $ | 0.01 % |
| 305 | MoonLake Immunotherapeutics | 95,724 | 1.7M $ | 0.01 % |
| 306 | Monte Rosa Therapeutics Inc | 93,371 | 1.7M $ | 0.01 % |
| 307 | Varex Imaging Corp | 124,595 | 1.6M $ | 0.01 % |
| 308 | Janux Therapeutics Inc | 118,129 | 1.6M $ | 0.01 % |
| 309 | Mesa Laboratories Inc | 16,578 | 1.6M $ | 0.01 % |
| 310 | Phathom Pharmaceuticals Inc | 126,819 | 1.6M $ | 0.01 % |
| 311 | CorMedix Inc | 222,764 | 1.6M $ | 0.01 % |
| 312 | Perspective Therapeutics Inc | 290,827 | 1.6M $ | 0.01 % |
| 313 | OPKO Health, Inc. | 1,271,801 | 1.5M $ | 0.01 % |
| 314 | ARS Pharmaceuticals Inc | 163,427 | 1.5M $ | 0.01 % |
| 315 | Tango Therapeutics Inc | 135,189 | 1.5M $ | 0.01 % |
| 316 | Ironwood Pharmaceuticals Inc | 439,728 | 1.5M $ | 0.01 % |
| 317 | Vanda Pharmaceuticals Inc | 168,602 | 1.5M $ | 0.01 % |
| 318 | HealthStream Inc | 70,648 | 1.5M $ | 0.01 % |
| 319 | Cytek Biosciences Inc | 326,812 | 1.5M $ | 0.01 % |
| 320 | Cerus Corp | 569,104 | 1.5M $ | 0.01 % |
| 321 | Personalis Inc | 159,822 | 1.4M $ | 0.01 % |
| 322 | Kestra Medical Technologies Ltd | 60,579 | 1.4M $ | 0.01 % |
| 323 | AngioDynamics Inc | 122,977 | 1.4M $ | 0.01 % |
| 324 | ArriVent Biopharma Inc | 61,008 | 1.4M $ | 0.01 % |
| 325 | Cullinan Therapeutics Inc | 88,832 | 1.4M $ | 0.01 % |
| 326 | KalVista Pharmaceuticals Inc | 83,620 | 1.4M $ | 0.01 % |
| 327 | Tyra Biosciences Inc | 40,280 | 1.3M $ | 0.01 % |
| 328 | Community Health Systems Inc | 382,981 | 1.3M $ | 0.01 % |
| 329 | Emergent BioSolutions Inc | 159,609 | 1.3M $ | 0.01 % |
| 330 | Pacific Biosciences of California Inc | 772,607 | 1.3M $ | 0.01 % |
| 331 | Orthofix Medical Inc | 94,830 | 1.3M $ | 0.01 % |
| 332 | Myriad Genetics Inc | 276,946 | 1.3M $ | 0.01 % |
| 333 | ZENAS BIOPHARMA INC | 48,147 | 1.3M $ | 0.01 % |
| 334 | Allogene Therapeutics Inc | 452,327 | 1.3M $ | 0.01 % |
| 335 | Savara Inc | 207,988 | 1.3M $ | 0.01 % |
| 336 | Rocket Pharmaceuticals Inc | 244,381 | 1.2M $ | 0.01 % |
| 337 | CryoPort Inc | 143,089 | 1.2M $ | 0.01 % |
| 338 | Prime Medicine Inc | 259,551 | 1.2M $ | 0.01 % |
| 339 | Prothena Corp PLC | 137,710 | 1.2M $ | 0.01 % |
| 340 | Maravai LifeSciences Holdings Inc | 326,406 | 1.2M $ | 0.01 % |
| 341 | REGENXBIO Inc | 127,897 | 1.2M $ | 0.01 % |
| 342 | Aveanna Healthcare Holdings Inc | 156,754 | 1.2M $ | 0.01 % |
| 343 | Altimmune Inc | 265,544 | 1.1M $ | 0.01 % |
| 344 | Pulse Biosciences Inc | 61,062 | 1.1M $ | 0.01 % |
| 345 | Anavex Life Sciences Corp | 256,023 | 1.1M $ | 0.01 % |
| 346 | Replimune Group Inc | 140,906 | 1.1M $ | 0.01 % |
| 347 | Bioventus Inc | 120,559 | 1.1M $ | 0.01 % |
| 348 | Ceribell Inc | 54,989 | 1M $ | 0.01 % |
| 349 | 4D Molecular Therapeutics Inc | 105,389 | 1M $ | 0.01 % |
| 350 | OrthoPediatrics Corp | 52,580 | 1M $ | 0.01 % |
| 351 | MeiraGTx Holdings plc | 131,531 | 994.4K $ | 0.00 % |
| 352 | Akebia Therapeutics Inc | 757,990 | 993K $ | 0.00 % |
| 353 | Evolent Health Inc | 300,475 | 976.5K $ | 0.00 % |
| 354 | Septerna Inc | 33,480 | 971.6K $ | 0.00 % |
| 355 | Bicara Therapeutics Inc | 57,294 | 961.4K $ | 0.00 % |
| 356 | Fulcrum Therapeutics Inc | 113,751 | 953.2K $ | 0.00 % |
| 357 | Fulgent Genetics Inc | 59,813 | 916.9K $ | 0.00 % |
| 358 | Aldeyra Therapeutics Inc | 155,899 | 851.2K $ | 0.00 % |
| 359 | Standard BioTools Inc | 747,537 | 844.7K $ | 0.00 % |
| 360 | SIGA Technologies Inc | 130,376 | 843.5K $ | 0.00 % |
| 361 | Quanterix Corp | 125,718 | 823.5K $ | 0.00 % |
| 362 | LEXICON PHARMACEUTICALS INC | 548,799 | 806.7K $ | 0.00 % |
| 363 | Ardent Health Inc | 85,780 | 805.5K $ | 0.00 % |
| 364 | RxSight Inc | 104,675 | 783K $ | 0.00 % |
| 365 | Cross Country Healthcare Inc | 88,741 | 772K $ | 0.00 % |
| 366 | Aura Biosciences Inc | 130,798 | 770.4K $ | 0.00 % |
| 367 | XOMA Royalty Corp | 29,011 | 740.7K $ | 0.00 % |
| 368 | Verastem Inc | 129,463 | 740.5K $ | 0.00 % |
| 369 | Atea Pharmaceuticals Inc | 155,056 | 725.7K $ | 0.00 % |
| 370 | Keros Therapeutics Inc | 49,534 | 702.9K $ | 0.00 % |
| 371 | Rezolute Inc | 218,368 | 701K $ | 0.00 % |
| 372 | Entrada Therapeutics Inc | 57,598 | 687.1K $ | 0.00 % |
| 373 | Ginkgo Bioworks Holdings Inc | 99,142 | 669.2K $ | 0.00 % |
| 374 | Simulations Plus Inc | 52,274 | 639.3K $ | 0.00 % |
| 375 | Evolus Inc | 144,566 | 621.6K $ | 0.00 % |
| 376 | Organogenesis Holdings Inc | 190,756 | 612.3K $ | 0.00 % |
| 377 | Arcturus Therapeutics Holdings Inc | 73,875 | 608K $ | 0.00 % |
| 378 | Neumora Therapeutics Inc | 171,100 | 597.1K $ | 0.00 % |
| 379 | Editas Medicine Inc | 270,431 | 594.9K $ | 0.00 % |
| 380 | OraSure Technologies Inc | 188,856 | 594.9K $ | 0.00 % |
| 381 | Alector Inc | 241,487 | 586.8K $ | 0.00 % |
| 382 | Accendra Health Inc | 232,854 | 563.5K $ | 0.00 % |
| 383 | Lyell Immunopharma Inc | 23,103 | 554.5K $ | 0.00 % |
| 384 | agilon health Inc | 938,023 | 552.8K $ | 0.00 % |
| 385 | Humacyte Inc | 478,723 | 533.8K $ | 0.00 % |
| 386 | Heron Therapeutics Inc | 418,992 | 498.6K $ | 0.00 % |
| 387 | GoodRx Holdings Inc | 259,964 | 486.1K $ | 0.00 % |
| 388 | Atrium Therapeutics Inc | 32,849 | 484.5K $ | 0.00 % |
| 389 | LENZ Therapeutics Inc | 35,168 | 474.4K $ | 0.00 % |
| 390 | Quantum-Si Inc | 493,459 | 471.9K $ | 0.00 % |
| 391 | OmniAb Inc | 259,648 | 446.6K $ | 0.00 % |
| 392 | Fate Therapeutics Inc | 295,141 | 436.8K $ | 0.00 % |
| 393 | Zentalis Pharmaceuticals Inc | 151,885 | 363K $ | 0.00 % |
| 394 | Health Catalyst Inc | 210,413 | 340.9K $ | 0.00 % |
| 395 | Upstream Bio Inc | 40,484 | 310.9K $ | 0.00 % |
| 396 | MacroGenics Inc | 155,000 | 308.5K $ | 0.00 % |
| 397 | Filana Therapeutics Inc | 133,221 | 303.7K $ | 0.00 % |
| 398 | Treace Medical Concepts Inc | 151,893 | 282.5K $ | 0.00 % |
| 399 | MaxCyte Inc | 304,528 | 247.1K $ | 0.00 % |
| 400 | Claritev Corp | 17,334 | 233.5K $ | 0.00 % |
Sector breakdown
- Health care 85.8 %
- Technology 0.4 %
- Unattributed 13.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 99.4 %
- Ireland 0.3 %
- Bermuda 0.2 %
- Canada 0.1 %
- British Virgin Islands 0.0 %
- Netherlands 0.0 %
- Singapore 0.0 %
- Jersey 0.0 %
- Cayman Islands 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 392 | 20.1B $ | 99.39 % |
| 2 | Ireland | 4 | 52M $ | 0.26 % |
| 3 | Bermuda | 2 | 34M $ | 0.17 % |
| 4 | Canada | 3 | 11.6M $ | 0.06 % |
| 5 | British Virgin Islands | 2 | 8.2M $ | 0.04 % |
| 6 | Netherlands | 1 | 4.8M $ | 0.02 % |
| 7 | Singapore | 1 | 4.7M $ | 0.02 % |
| 8 | Jersey | 1 | 4.4M $ | 0.02 % |
| 9 | Cayman Islands | 2 | 2.7M $ | 0.01 % |
Cite this page
Titelia. "Holdings of VANGUARD HEALTH CARE INDEX FUND". https://titelia.com/en/funds/S000004450